These data suggest that dysregulation of LRP6 function in the brain leads to suppression of Wnt/β-catenin signaling and exacerbation of Alzheimer’s disease symptoms. The gene discussed is LRP6; the disease is early-onset autosomal dominant Alzheimer disease.